Ninety miles from the South Eastern tip of the United States, Liberty has no stead. In order for Liberty to exist and thrive, Tyranny must be identified, recognized, confronted and extinguished.
infinite scrolling
Saturday, February 4, 2023
Moderna Announces mRNA Vaccine To Treat ‘Sudden’ Surge in Turbo-Cancers
Big Pharma giant Moderna has announced plans to launch an mRNA vaccine to treat the sudden surge in turbo-cancers that has occurred following the COVID jab rollout.
During the recent World Economic Forum in Davos, Switzerland, Moderna CEO Stephane Bancel admitted that he would “like to have mRNA capacity on every continent.”
“The mRNA technology rollout is so concerning,” said Tracy Beanz, news and editorial contributor for The HighWire. “They’d never tested this on humans before March of 2020, and now they’re pushing this lipid nanoparticle into the arms of every citizen on the planet.”
“And they’re not looking to stop with just the [Wuhan coronavirus] COVID vaccines,” continued Beanz. “They’re expanding.” She boasted that Moderna is planning to release mRNA-based vaccines for other common health conditions like MERS, SARS, Marburg virus disease and the Zika fever.
Naturalnews.com reports: Moderna is also developing mRNA-based vaccines for respiratory syncytial virus (RSV) and an aggressive type of skin cancer.
The Big Pharma company’s RSV vaccine is already in phase 3 of trial testing, with data released by the company claiming it is 83.7 percent effective at preventing moderate cases of the disease, which is defined as a bout of RSV with two or more symptoms. The company further claimed that the vaccine candidate is 82.4 percent effective at dealing with a severe case of RSV, defined by having three or more symptoms.
Moderna hopes to get the Food and Drug Administration to approve of the company’s RSV vaccine by the end of the year.
The company’s skin cancer mRNA vaccine, which it is developing with Merck, is allegedly showing promise in its phase 2 trial.
Data released by the company claimed that the mRNA vaccine, when used in combination with an immunotherapy drug called Keytruda sold by Merck, reduced the risk of death or recurrence of melanoma in high-risk patients by 44 percent compared with treatment using only Keytruda.
The phase 2 trial enrolled 157 participants. Due to its so-called early successes, Bancel is preparing to move Moderna toward holding larger phase 3 trials. These trials will involve the company testing the vaccine and immunotherapy drug combination with other kinds of cancer, with Bancel claiming that it “should work in...
During the recent World Economic Forum in Davos, Switzerland, Moderna CEO Stephane Bancel admitted that he would “like to have mRNA capacity on every continent.”
“The mRNA technology rollout is so concerning,” said Tracy Beanz, news and editorial contributor for The HighWire. “They’d never tested this on humans before March of 2020, and now they’re pushing this lipid nanoparticle into the arms of every citizen on the planet.”
“And they’re not looking to stop with just the [Wuhan coronavirus] COVID vaccines,” continued Beanz. “They’re expanding.” She boasted that Moderna is planning to release mRNA-based vaccines for other common health conditions like MERS, SARS, Marburg virus disease and the Zika fever.
Naturalnews.com reports: Moderna is also developing mRNA-based vaccines for respiratory syncytial virus (RSV) and an aggressive type of skin cancer.
The Big Pharma company’s RSV vaccine is already in phase 3 of trial testing, with data released by the company claiming it is 83.7 percent effective at preventing moderate cases of the disease, which is defined as a bout of RSV with two or more symptoms. The company further claimed that the vaccine candidate is 82.4 percent effective at dealing with a severe case of RSV, defined by having three or more symptoms.
Moderna hopes to get the Food and Drug Administration to approve of the company’s RSV vaccine by the end of the year.
The company’s skin cancer mRNA vaccine, which it is developing with Merck, is allegedly showing promise in its phase 2 trial.
Data released by the company claimed that the mRNA vaccine, when used in combination with an immunotherapy drug called Keytruda sold by Merck, reduced the risk of death or recurrence of melanoma in high-risk patients by 44 percent compared with treatment using only Keytruda.
The phase 2 trial enrolled 157 participants. Due to its so-called early successes, Bancel is preparing to move Moderna toward holding larger phase 3 trials. These trials will involve the company testing the vaccine and immunotherapy drug combination with other kinds of cancer, with Bancel claiming that it “should work in...
Planned New FBI HQ Is Twice the Size of the Pentagon
The GOP House can stop the project and rein in a runaway bureau.
The federal government is proceeding with plans to build a new FBI headquarters complex twice the size of the Pentagon building.
Riveted into the colossal new project are woke regulations to ensure that the FBI center will comply with diversity, equity, LGBTQ+, and climate change political goals.
The plan, unveiled last September, has received little attention. For years the FBI has sought to vacate its present headquarters, a brutalist concrete bunker on stilts and occupying two city blocks between the White House and the Capitol.
Plans for the new FBI headquarters specify that it will be built on one of three sites in suburban Virginia and Maryland. Those sites are large parcels of 58, 61, and 80 acres.
That means, at minimum, the new FBI headquarters complex would be twice the size of the Pentagon building. Covering about 29 acres plus a five-acre courtyard, the Pentagon, until recently, was the largest office building on earth.
The Kremlin in Moscow —a walled fortress containing the administrative offices of the Russian central government, the official presidential residence, massive auditoriums, an arsenal, a museum, four palaces, three cathedrals and several churches—is just over 66 acres in area.
The General Services Administration, which administers federal properties, has selected the three sites. The 58-acre property in Springfield, Virginia, GSA says, is “federally owned land under the jurisdiction, custody, and control of GSA.”
The government would have to buy or lease either of the two properties available in Maryland. The State of Maryland and the Washington Metropolitan Area Transit Authority own the 61-acre site in Greenbelt. The 80-acre parcel is the former Landover Mall, which is privately owned.
GSA set out five criteria for choosing the property: FBI mission requirement; transportation access for FBI personnel; site development flexibility, which includes the suitability of the actual property and the earliest time construction could begin; promoting sustainable siting and advancing equity; and cost.
Of those five criteria, cost to the taxpayer is viewed as least important. The equity criterion, to comply with diversity and climate-change executive orders signed by Joe Biden, is weighted as 50 percent more important than the cost.
The site, design, and structure of the new FBI headquarters must “advance racial equity and support for underserved communities through the Federal Government,” GSA says, citing Executive Orders 13985 and 14057. The FBI complex must be a “sustainable location” to “strengthen the vitality and livability of the communities” in the area, according to GSA.
On his first day as president, Biden signed Executive Order 13985 as part of what he called “an ambitious whole-of-government equity agenda.”
The executive order defines “equity” as “the consistent and systematic fair, just, and impartial treatment of all individuals, including individuals who belong to underserved communities that have been denied such treatment, such as Black, Latino, and Indigenous and Native American persons, Asian Americans and Pacific Islanders and other persons of color; members of religious minorities; lesbian, gay, bisexual, transgender, and queer (LGBTQ+) persons,” and so on.
That is one of the main factors driving the location of the new, double-Pentagon-sized FBI headquarters.
Biden signed the other part of the equity criterion, Executive Order 14057, in December 2021 to push his climate change agenda. That order directs that it is the policy of the federal government to “create and sustain . . . well-paying union jobs” and a range of other issues, including...
The 90 Miles Mystery Video: Nyctophilia Edition #1284
Before You Click On The "Read More" Link,
Please Only Do So If You Are Over 21 Years Old.
If You are Easily Upset, Triggered Or Offended, This Is Not The Place For You.
Please Leave Silently Into The Night......
The 90 Miles Mystery Box: Episode #1984 - 1984 Edition!
You have come across a mystery box. But what is inside?
It could be literally anything from the serene to the horrific,
from the beautiful to the repugnant,
from the mysterious to the familiar.
If you decide to open it, you could be disappointed,
you could be inspired, you could be appalled.
This is not for the faint of heart or the easily offended.
You have been warned.
Friday, February 3, 2023
Subscribe to:
Posts (Atom)